Natco Pharma announced final approval of its ANDA for Bosentan tablets for oral suspension (TFOS), 32mg, a generic version of Tracleer by Actelion Pharmaceuticals US Inc. NATCO's marketing partner for ...

Taiyo Yuden will benefit from increased passive components per phone as a result of advancing technology in telecommunications. In particular, diffusion of LTE and LTE-advanced networks and phones ...

Apple is again leading the tablet market with its iPad lineup. In the fourth quarter of 2024, Apple was able to secure 42.3 ...

We recently published a list of 10 Small–Cap Stocks Insiders Are Buying Recently. In this article, we are going to take a ...

Apple reportedly dominated the tablet market in Q4 2024, capturing 42.3 per cent market share all thanks to its strong iPad ...

Undoubtedly, the Apple iPad is the most popular tablet in the world and completely dominates. This is why all the big ...

Apple's iPad continues to lead the global tablet market with a 38.6% share, shipping 57 million units in 2024. Strong ...

Whether for work, school, or entertainment, Apple’s iPads continue to rule the global smartphone market. Meanwhile, Android tablets are still struggling to catch up ...

Xiaomi experienced 73.1% annual growth and is now a top-five brand. Global tablet shipments grew by 9% in 2024, reaching ...

Back in October, during the Snapdragon Summit, news broke that ARM was going to terminate its licensing agreement with ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...

Lupin: Drug manufacturer Lupin Ltd. received tentative approval from the U.S. FDA for its generic version of a combination ...